Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Personalized Outpatient Rehabilitation Treatment After Tka

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Personalized Outpatient Rehabilitation Treatment After Tka1
  • Standard Outpatient Rehabilitation Treatment After Tka1
  • Zimmer Nexgen Trabecular Metal Technology Tmt Modular1
  • Zimmer Nexgen Trabecular Metal Technology Tmt Monoblock1

Active Sponsors

  • Università degli Studi 'G. d'Annunzio' Chieti e Pescara1
  • Copenhagen University Hospital, Rigshospitalet1
  • Zimmer Biomet1
  • Laura Belinda Rizzo1

Top Investigators

Activity Timeline